Abstract
The aim of this study is to describe the comorbidity profile in patients with early and established psoriatic arthritis (PsA). Patients with PsA were selected from a registry of patients with psoriasis in Newfoundland. Patients with a diagnosis of psoriasis according to the CASPAR classification criteria are entered in the registry at the time of diagnosis, questioned on their medical history, and are followed indefinitely. Patients who were diagnosed with PsA within the last 2 years were included in the early PsA cohort, whereas the established cohort was comprised of patients with a diagnosis for ≥2 years. The general population of Newfoundland without psoriasis or PsA was used as external standard to conduct age- and gender-adjusted comparison of the comorbidity profile of the PsA cohorts to the general population. A total of 108 (65.5%) and 57 (34.5%) patients were included in the established and early PsA cohort, respectively. Patients with early and established PsA had significantly higher age- and gender-adjusted prevalence of hypertension, diabetes, depression, Crohn's disease, and chronic obstructive pulmonary disease. In addition, in the early PsA cohort, the age-adjusted prevalence of coronary heart disease and angina was significantly higher when compared to the general population. Distinct comorbidities are associated with PsA even at early stages of disease progression, the early detection and management of which could improve the patients' disability, morbidity, and quality of life.
Similar content being viewed by others
References
Gladman DD (2004) Psoriatic arthritis. Dermatol Ther 17:350–363. doi:10.1111/j.1396-0296.2004.04038.x
Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511–517
Salomon J, Szepietowski JC, Proniewiez A (2003) Psoriatic nails: a prospective clinical study. J Cutan Med Surg 7:317–321. doi:10.1007/s10227-002-0143-0
Kane D, Stafford L, Breshihan B, FitzgGerlad O (2003) A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 42:1460–1468. doi:10.1093/rheumatology/keg384
Gladman D (1994) The natural history of psoriatic arthritis. In: Wright V, Helliwell PS (eds) Psoriatic arthritis in Baillière's clinical rheumatology international practice and research. Baillière Tindall, London, pp 379–394
Gladman DD (2004) Psoriatic arthritis. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, Breedveld F (eds) Oxford textbook of rheumatology, 3rd edn. Oxford University Press, Oxford, pp 766–778
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64:ii14–ii17. doi:10.1136/ard.2004.032482
Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55–78
Gladman DD (1995) Psoriatic arthritis. Baillieres Clin Rheumatol 9:319–329
Jullien D, Barker J (2006) Genetics of psoriasis. J Eur Acad Dermatol Venereol 20:42–51. doi:10.1111/j.1468-3083.2006.01772.x
Gelfand JM, Gladman DD, Mease PJ et al (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573–577. doi:10.1016/j.jaad.2005.03.046
Anandarajah AP, Ritchlin CT (2009) The diagnosis and treatment of early psoriatic arthritis. Nat Rev Rheumatol 5:634–641. doi:10.1038/nrrheum.2009.210
Crofford LJ (2001) Psoriatic arthritis. In: Klippel JH (ed) Primer on the rheumatic diseases, 12th edn. Arthritis Foundation, Atlanta, pp 234–238
Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11:229–244. doi:10.1186/ar2669
Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673. doi:10.1002/art.21972
Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172
Kimball AB, Robinson D Jr, Wu Y et al (2008) Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002. Dermatology 217:27–37. doi:10.1159/000121333
Lee FI, Bellary SV, Francis C (1990) Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 85:962–963. doi:10.1111/j.1572-0241.1990.tb06788.x
McGovern DP, van Heel DA, Ahmad T, Jewell DP (2001) NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut 49:752–754. doi:10.1136/gut.49.6.752
Ho P, Bruce IN, Silman A et al (2005) Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum 52:3596–3602. doi:10.1002/art.21393
Rahman P, Bartlett S, Siannis F et al (2003) CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet 73:677–681. doi:10.1086/378076
Disclosures
Majed Khraishi is partially funded by non-restricted grants from Abbott Canada, Amgen/Wyeth Canada and supported by JSS Medical Research Inc. Don McDonald declared none. Emmanouil Rampakakis, Julie Vaillancourt, and John S. Sampalis are employees of JSS Medical Research Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khraishi, M., MacDonald, D., Rampakakis, E. et al. Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts. Clin Rheumatol 30, 877–885 (2011). https://doi.org/10.1007/s10067-011-1692-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1692-7